Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)
Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Journal of the National Cancer Center |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667005423000492 |
| _version_ | 1797429552790634496 |
|---|---|
| author | Jianchun Duan Wenfeng Fang Hairong Xu Jinliang Wang Yuan Chen Yi Ding Xiaorong Dong Yun Fan Beili Gao Jie Hu Yan Huang Cheng Huang Dingzhi Huang Wenhua Liang Lizhu Lin Hui Liu Zhiyong Ma Meiqi Shi Yong Song Chuanhao Tang Jialei Wang Lifeng Wang Yongfeng Wang Zhehai Wang Nong Yang Yu Yao Yan Yu Qitao Yu Hongmei Zhang Jun Zhao Mingfang Zhao Zhengfei Zhu Xiaohui Niu Li Zhang Jie Wang |
| author_facet | Jianchun Duan Wenfeng Fang Hairong Xu Jinliang Wang Yuan Chen Yi Ding Xiaorong Dong Yun Fan Beili Gao Jie Hu Yan Huang Cheng Huang Dingzhi Huang Wenhua Liang Lizhu Lin Hui Liu Zhiyong Ma Meiqi Shi Yong Song Chuanhao Tang Jialei Wang Lifeng Wang Yongfeng Wang Zhehai Wang Nong Yang Yu Yao Yan Yu Qitao Yu Hongmei Zhang Jun Zhao Mingfang Zhao Zhengfei Zhu Xiaohui Niu Li Zhang Jie Wang |
| author_sort | Jianchun Duan |
| collection | DOAJ |
| description | Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis. |
| first_indexed | 2024-03-09T09:15:46Z |
| format | Article |
| id | doaj.art-64c371bf622d46b68856e83b202c08a9 |
| institution | Directory Open Access Journal |
| issn | 2667-0054 |
| language | English |
| last_indexed | 2024-03-09T09:15:46Z |
| publishDate | 2023-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of the National Cancer Center |
| spelling | doaj.art-64c371bf622d46b68856e83b202c08a92023-12-02T07:07:04ZengElsevierJournal of the National Cancer Center2667-00542023-12-0134256265Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)Jianchun Duan0Wenfeng Fang1Hairong Xu2Jinliang Wang3Yuan Chen4Yi Ding5Xiaorong Dong6Yun Fan7Beili Gao8Jie Hu9Yan Huang10Cheng Huang11Dingzhi Huang12Wenhua Liang13Lizhu Lin14Hui Liu15Zhiyong Ma16Meiqi Shi17Yong Song18Chuanhao Tang19Jialei Wang20Lifeng Wang21Yongfeng Wang22Zhehai Wang23Nong Yang24Yu Yao25Yan Yu26Qitao Yu27Hongmei Zhang28Jun Zhao29Mingfang Zhao30Zhengfei Zhu31Xiaohui Niu32Li Zhang33Jie Wang34CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Respiratory Medicine, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, ChinaDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, ChinaDepartment of Oncology and Institute of Translational Medicine, Medical Innovation Research Center and the Fifth Medical Center, Chinese PLA General Hospital, Beijing, ChinaDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, ChinaCancer Center, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaDepartment of Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, ChinaDepartment of Respiratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Medical Oncology, Fujian Cancer Hospital, Fuzhou, ChinaDepartment of Thoracic Medical Oncology, Lung Cancer Diagnosis and Treatment Centre, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Centre for Cancer, Tianjin, ChinaDepartment of Thoracic Surgery/Oncology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Disease & Health, Guangzhou, ChinaDepartment of Medical Oncology, The First Clinical Medical College, the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, ChinaDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, ChinaDepartment of Medical Oncology, the Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Zhengzhou, ChinaDepartment of Medical Oncology, Jiangsu Cancer Hospital, Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Respiratory and Critical Care Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, ChinaDepartment of Oncology, Peking University International Hospital, Beijing, ChinaDepartment of Oncology, Fudan University Shanghai Cancer Center, Shanghai, ChinaComprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Nanjing, ChinaDepartment of Respiratory Medicine, Linyi Central Hospital, Linyi, ChinaDepartment of Oncology, Shandong Cancer Hospital, Jinan, ChinaDepartment of Medical Oncology, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, ChinaDepartment of Oncology Internal Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, ChinaSchool of Public Health, Xi'an Jiaotong University, Xi'an, ChinaDepartment of Respiratory Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, ChinaDepartment of Clinical Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, ChinaDepartment of Thoracic Medical Oncology, Peking University Cancer Hospital & Institute, Beijing, ChinaDepartment of Medical Oncology, the First Hospital of China Medical University, Shenyang, ChinaDepartment of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, ChinaDepartment of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China; Corresponding authors.Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; Corresponding authors.CAMS Key Laboratory of Translational Research on Lung Cancer, State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Corresponding authors.Lung cancer is the leading cause of cancer-related deaths worldwide. Bone is a common metastatic site of lung cancer, about 50% of bone metastatic patients will experience skeletal related events (SREs). SREs not only seriously impact the quality of life of patients, but also shorten their survival time. The treatment of bone metastasis requires multi-disciplinary therapy (MDT) and development of individualized treatment plan. In order to standardize the diagnosis and treatment of bone metastasis in lung cancer, the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis.http://www.sciencedirect.com/science/article/pii/S2667005423000492Lung cancerBone metastasisMulti-disciplinary therapyBone-modifying drugs |
| spellingShingle | Jianchun Duan Wenfeng Fang Hairong Xu Jinliang Wang Yuan Chen Yi Ding Xiaorong Dong Yun Fan Beili Gao Jie Hu Yan Huang Cheng Huang Dingzhi Huang Wenhua Liang Lizhu Lin Hui Liu Zhiyong Ma Meiqi Shi Yong Song Chuanhao Tang Jialei Wang Lifeng Wang Yongfeng Wang Zhehai Wang Nong Yang Yu Yao Yan Yu Qitao Yu Hongmei Zhang Jun Zhao Mingfang Zhao Zhengfei Zhu Xiaohui Niu Li Zhang Jie Wang Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition) Journal of the National Cancer Center Lung cancer Bone metastasis Multi-disciplinary therapy Bone-modifying drugs |
| title | Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition) |
| title_full | Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition) |
| title_fullStr | Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition) |
| title_full_unstemmed | Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition) |
| title_short | Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition) |
| title_sort | chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer 2022 edition |
| topic | Lung cancer Bone metastasis Multi-disciplinary therapy Bone-modifying drugs |
| url | http://www.sciencedirect.com/science/article/pii/S2667005423000492 |
| work_keys_str_mv | AT jianchunduan chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT wenfengfang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT hairongxu chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT jinliangwang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yuanchen chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yiding chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT xiaorongdong chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yunfan chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT beiligao chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT jiehu chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yanhuang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT chenghuang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT dingzhihuang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT wenhualiang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT lizhulin chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT huiliu chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT zhiyongma chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT meiqishi chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yongsong chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT chuanhaotang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT jialeiwang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT lifengwang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yongfengwang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT zhehaiwang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT nongyang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yuyao chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT yanyu chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT qitaoyu chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT hongmeizhang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT junzhao chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT mingfangzhao chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT zhengfeizhu chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT xiaohuiniu chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT lizhang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition AT jiewang chineseexpertconsensusonthediagnosisandtreatmentofbonemetastasisinlungcancer2022edition |